Summit Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $773k | 296k | 2.61 |
| 2023-09-30 | $400k | 214k | 1.87 |
| 2023-06-30 | $292k | 116k | 2.51 |
| 2023-03-31 | $40k | 23k | 1.73 |
| 2022-12-31 | $59k | 14k | 4.31 |
| 2022-06-30 | $8.2k | 5.1k | 1.59 |
| 2022-03-31 | $58k | 24k | 2.43 |
| 2021-12-31 | $89k | 34k | 2.67 |
| 2021-03-31 | $142k | 24k | 5.87 |
| 2020-12-31 | $2.3M | 494k | 4.70 |
| 2020-09-30 | $5.5M | 1.6M | 3.50 |